Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$7.06 - $23.63 $75,986 - $254,329
-10,763 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$21.6 - $27.79 $45,360 - $58,359
2,100 Added 24.24%
10,763 $245,000
Q4 2021

Feb 10, 2022

BUY
$23.0 - $29.01 $199,249 - $251,313
8,663 New
8,663 $239,000
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $181,590 - $217,995
-7,252 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$27.43 - $32.7 $1.23 Million - $1.47 Million
-44,891 Reduced 86.09%
7,252 $212,000
Q1 2021

May 10, 2021

BUY
$21.37 - $34.38 $824,668 - $1.33 Million
38,590 Added 284.73%
52,143 $1.66 Million
Q4 2020

Feb 10, 2021

BUY
$15.31 - $21.12 $30,558 - $42,155
1,996 Added 17.27%
13,553 $282,000
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $18,674 - $25,263
-1,255 Reduced 9.8%
11,557 $180,000
Q2 2020

Aug 10, 2020

SELL
$13.31 - $20.51 $391,979 - $604,019
-29,450 Reduced 69.68%
12,812 $234,000
Q1 2020

May 21, 2020

BUY
$12.98 - $30.25 $548,560 - $1.28 Million
42,262 New
42,262 $657,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $1.05 Million - $1.77 Million
-55,382 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$20.88 - $25.66 $875,916 - $1.08 Million
-41,950 Reduced 43.1%
55,382 $1.21 Million
Q2 2019

Aug 13, 2019

SELL
$20.52 - $26.45 $1.39 Million - $1.8 Million
-67,921 Reduced 41.1%
97,332 $2.46 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $1.32 Million - $1.71 Million
-65,091 Reduced 28.26%
165,253 $4.08 Million
Q4 2018

Feb 14, 2019

SELL
$17.64 - $28.32 $504,010 - $809,159
-28,572 Reduced 11.04%
230,344 $4.25 Million
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $5.34 Million - $6.65 Million
258,916 New
258,916 $6.65 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.82B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.